News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,919 Results
Type
Article (8398)
Company Profile (140)
Press Release (479380)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (167629)
Career Advice (310)
Deals (25825)
Drug Delivery (8)
Drug Development (53280)
Employer Resources (14)
FDA (9819)
Job Trends (8636)
News (239571)
Policy (18032)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (521)
Accelerated approval (25)
ADA (18)
Adcomms (1)
Allergies (103)
Alliances (33375)
ALS (105)
Alzheimer's disease (994)
Antibody-drug conjugate (ADC) (268)
Approvals (10438)
Artificial intelligence (327)
ASCO (159)
Autoimmune disease (207)
Automation (28)
Bankruptcy (262)
Best Places to Work (7005)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (516)
Cancer (3699)
Cardiovascular disease (219)
Career advice (250)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (34)
Clinical research (48236)
Collaboration (1258)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (777)
CRISPR (64)
C-suite (755)
Cystic fibrosis (87)
Data (5716)
Denatured (4)
Depression (102)
Dermatology (62)
Diabetes (348)
Diagnostics (4227)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73870)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88146)
Executive appointments (709)
FDA (12468)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (938)
Gene editing (126)
Generative AI (9)
Gene therapy (322)
GLP-1 (295)
Government (967)
Grass and pollen (3)
Guidances (284)
Healthcare (9467)
Hematology (100)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (58)
Indications (157)
Infectious disease (967)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (43)
IPO (12419)
IRA (2)
Job creations (1988)
Job search strategy (240)
JPM (2)
Kidney cancer (16)
Layoffs (60)
Legal (5230)
Licensing (8)
Liver cancer (46)
Longevity (17)
Lung cancer (516)
Lymphoma (268)
Machine learning (27)
Management (3)
Manufacturing (539)
Marketing (8)
MASH (122)
Medical device (8706)
Medtech (8851)
Mergers & acquisitions (14448)
Metabolic disorders (718)
mRNA (56)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (222)
Neuropsychiatric disorders (39)
Neuroscience (1853)
NextGen: Class of 2026 (3196)
Non-profit (896)
Obesity (227)
Opinion (22)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (197)
Parkinson's disease (206)
Partnered (12)
Patents (476)
Patient recruitment (514)
Peanut (35)
People (41652)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15581)
Phase 2 (21513)
Phase 3 (14538)
Pipeline (7389)
Policy (18)
Postmarket research (1595)
Preclinical (6574)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (192)
Rare diseases (585)
Real estate (3058)
Recruiting (6)
Regulatory (14927)
Reports (21)
Research institute (607)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (101)
Series A (161)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2044)
Stomach cancer (3)
Supply chain (50)
The Weekly (1)
Vaccines (326)
Venture capital (17)
Weight loss (74)
Women's health (79)
Date
Today (9)
Last 7 days (203)
Last 30 days (1556)
Last 365 days (19193)
2026 (12430)
2025 (19431)
2024 (23129)
2023 (26712)
2022 (34755)
2021 (37387)
2020 (33669)
2019 (23568)
2018 (17719)
2017 (18938)
2016 (18079)
2015 (24459)
2014 (21803)
2013 (18268)
2012 (20318)
2011 (20558)
2010 (20427)
Location
Africa (237)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (18036)
Australia (2122)
California (12023)
Canada (3160)
China (543)
Colorado (485)
Connecticut (411)
Delaware (209)
Europe (25785)
Florida (1793)
Georgia (380)
Hawaii (3)
Idaho (47)
Illinois (707)
India (51)
Indiana (317)
Iowa (15)
Japan (400)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (27)
Maryland (1202)
Massachusetts (7874)
Michigan (308)
Minnesota (559)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2628)
New Mexico (12)
New York (2842)
North Carolina (1279)
North Dakota (4)
Northern California (6040)
Ohio (283)
Oklahoma (14)
Oregon (19)
Pennsylvania (2262)
Puerto Rico (20)
Rhode Island (30)
South America (417)
South Carolina (76)
South Dakota (1)
Southern California (4977)
Tennessee (122)
Texas (1943)
United States (39029)
Utah (360)
Vermont (1)
Virginia (155)
Washington D.C. (39)
Washington State (942)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
487,919 Results for "henry schein inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET
January 22, 2026
·
2 min read
Press Releases
Henry Schein Reports Second Quarter 2025 Financial Results
August 6, 2025
·
19 min read
Press Releases
Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance
November 5, 2025
·
19 min read
Pharm Country
Henry Schein to Present at Investor Conferences in May 2024
Henry Schein, Inc. announced today that the Company will present at the following investor conferences in May.
April 29, 2024
·
2 min read
Press Releases
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET
October 21, 2025
·
2 min read
Press Releases
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
October 17, 2025
·
7 min read
Pharm Country
Henry Schein Presents THRIVELIVE 2024
Henry Schein, Inc. (Nasdaq: HSIC) announced today that it will host THRIVELIVE™ 2024, the Company’s annual dental event that celebrates innovation and community and provides a one-of-a-kind educational experience for dental professionals to learn how to grow their practices.
April 2, 2024
·
4 min read
Press Releases
Henry Schein Reports First Quarter 2025 Financial Results
May 5, 2025
·
20 min read
Deals
Henry Schein Completes Acquisition of Majority Interest of TriMed, Inc.
Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced it has completed the acquisition of TriMed, Inc., a global developer of solutions for the orthopedic treatment of lower extremities and upper extremities.
April 4, 2024
·
8 min read
Press Releases
Henry Schein to Participate in Upcoming Investor Conferences in May 2025
May 6, 2025
·
2 min read
1 of 48,792
Next
